Citigroup’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108K Sell
25,646
-29,829
-54% -$133K ﹤0.01% 4251
2025
Q4
$209K Buy
55,475
+51,201
+1,198% +$99.5K ﹤0.01% 3987
2025
Q3
$6.88K Sell
4,274
-38,141
-90% -$67.9K ﹤0.01% 5130
2025
Q2
$92.9K Buy
+42,415
New +$65.1K ﹤0.01% 4441
2023
Q1
Sell
-100
Closed -$236 5825
2022
Q4
$236 Buy
+100
New +$280 ﹤0.01% 5584
2022
Q2
Sell
-1,918
Closed -$13K 6623
2022
Q1
$13K Buy
+1,918
New +$11.2K ﹤0.01% 5403
2019
Q1
Sell
-12
Closed -$1K 7788
2018
Q4
$1K Hold
12
﹤0.01% 7594
2018
Q3
$1K Hold
12
﹤0.01% 7680
2018
Q2
$2K Hold
12
﹤0.01% 7475
2018
Q1
$2K Buy
+12
New +$3.43K ﹤0.01% 7378
2017
Q4
Sell
-3
Closed -$2K 7641
2017
Q3
$2K Sell
3
-2
-40% -$1.32K ﹤0.01% 7038
2017
Q2
$4K Buy
5
+2
+67% +$1.74K ﹤0.01% 6823
2017
Q1
$3K Sell
3
-4
-57% -$6.62K ﹤0.01% 6940
2016
Q4
$22K Buy
+7
New +$40.7K ﹤0.01% 6496

Other funds holding SLS